Stroke Clinical Trials in Madison, Wisconsin

4 studies are recruiting for stroke in Madison, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

    The purpose of this research is to determine if two non-invasive brain stimulation techniques, muscle stimulation of the arm and neuro-stimulation through the tongue, can increase the extent of stroke recovery.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Wisconsin, Madison, Wisconsin
    Run by
    University of Wisconsin, Madison

    See if you can join NCT02098265 on ClinicalTrials.gov

  2. Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

    VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, tra…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Wisconsin University Hospital, Madison, Wisconsin
    Locations
    45 in total
    Run by
    Yale University

    See if you can join NCT05338697 on ClinicalTrials.gov

  3. Neuroplasticity Biomarkers in Aphasia

    Patients with stroke frequently suffer from aphasia, a disorder of expressive and/or receptive language, that can lead to serious health consequences, including social isolation, depression, reduced quality of life, and increased caregiver burden. Aphasia recovery varies greatly between individuals…

    Stage
    Not phased
    Ages
    40 to 90
    Site
    UW School of Medicine and Public Health, Madison, Wisconsin
    Run by
    University of Wisconsin, Madison

    See if you can join NCT06471127 on ClinicalTrials.gov

  4. Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

    The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Wisconsin, Madison, Wisconsin
    Locations
    106 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT04045665 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.